118
Views
86
CrossRef citations to date
0
Altmetric
Review

Impact and treatment of cancer during pregnancy

, , &
Pages 889-902 | Published online: 10 Jan 2014

References

  • Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer 1 Clin. 53(1), 5–26 (2003).
  • Kennedy S, Yudkin P, Greenall M. Cancer in pregnancy. Eur.j Surg. Oncol 19(5), 405–407 (1993).
  • Smith RA. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA Cancer 1 Clin. 50(5), 312–336 (2000).
  • Sorosky JI, Scott-Conner CE. Breast disease complicating pregnancy. Obstet. CynecolGun. North Am. 25(2), 353–363 (1998).
  • Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist 7(4), 279–287 (2002).
  • Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Gun. Phatmacokinet. 28(3), 235–269 (1995).
  • Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin. Oncol 16(5), 337–346 (1989).
  • ••Comprehensive review of cancer treatmentduring pregnancy.
  • Schenker JG, Meirow D. Pharmacokinetics of the maternal fetal unit. In: The fetus As A Patient. Cagnazzo G, D'Addario V (Eds), Excerpta Medica, Amsterdam, The Netherlands (1989).
  • Witt KL, Bishop JB. Mutagenicity of anticancer drugs in mammalian germ cells. Mutat. Res. 355(1-2), 209–234 (1996).
  • Green DM, Zevon MA, Lowrie G, Seigelstein N, Hall B. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl. J. Med. 325(3), 141–146 (1991).
  • Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87(7), 3045–3052 (1996).
  • Sadler TW, Langman J. Lawman's Medical Embryology Lippincott Williams & Wilkins, MD, USA (2004).
  • Schardein JL. Chemically Induced Birth Defects, thin' edition. Marcel Dekker, Inc., NY, USA (2000).
  • Buekers TE, Lallas TA. Chemotherapy in pregnancy. Obstet. Cynecol Gun. North Am 25(2), 323–329 (1998).
  • •Review of chemotherapy in pregnancy.
  • Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Intern. Med. 152(3), 573–576 (1992).
  • •Well written review dealing with short- and long-term outcome of fetal cytotoxic therapy.
  • Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin. Oncol 16(5), 388–396 (1989).
  • Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch. Intern. Med. 148(9), 2058–2064 (1988).
  • Randall T National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA 269(3), 323 (1993).
  • Germann N, Goffinet F, Goldwasser E Anthracyclines during pregnancy: embryo—fetal outcome in 160 patients. Ann. Oncol 15(1), 146–150 (2004).
  • Meyer-Wittkopf M, Barth H, Emons G, Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet. Cynecol 18(1), 62–66 (2001).
  • Aviles A, Niz J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol 16(1), 3–6 (1988).
  • ••Excellent study assessing short- andlong-term effects of cancer therapy.
  • Aviles A, Diaz-Maqueo JC, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am. J. Hematol 36(4), 243–248 (1991).
  • ••Excellent study assessing short- andlong-term effects of cancer therapy.
  • Boffetta P, Kaldor JM. Secondary malignancies following cancer chemotherapy. Acta Oncol 33(6), 591–598 (1994).
  • Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin. Lymphoma2(3), 173–177 (2001).
  • Ward RM, Beachy JC. Neonatal complications following preterm birth. BE J. Obstet. Cynaecol 110\(Suppl. 20), 8–16 (2003).
  • Brent RL, Mettler FA. Pregnancy policy. All? Am. J. Roentgenol 182(3), 819–822 (2004).
  • •Very well written letter regarding the recommendation of counseling pregnant patients before diagnostic radiographic procedures (see [28) .
  • Brent RL. Utilization of developmental basic science principles in the evaluation of reproductive risks from pre- and postconception environmental radiation exposures. 7eratology59(4), 182–204 (1999).
  • El Khoury GY, Madsen MT, Blake ME, Yankowitz J. A new pregnancy policy for a new era. AJRAm.J Roentgenol 181(2), 335–340 (2003).
  • •Recommendations regarding radiation and pregnancy
  • Pils S, Muller WU, Streffer C. Lethal and teratogenic effects in two successive generations of the HLG mouse strain after radiation exposure of zygotes — association with genomic instability? Mutat. Res. 429(1), 85–92 (1999).
  • Fattibene P, Mazzei F, Nuccetelli C, Risica S. Prenatal exposure to ionizing radiation: sources, effects and regulatory aspects. Acta Paediatr 88(7), 693–702 (1999).
  • Miller RVV. Discussion: severe mental retardation and cancer among atomic bomb survivors exposed in utero. 7eratology59(4), 234–235 (1999).
  • Schull WJ, Otake M. Cognitive function and prenatal exposure to ionizing radiation. 7ratology59(4), 222–226 (1999).
  • Mole RII. The biology and radiobiology of in utero development in relation to radiological protection. BE j Radiol. 66(792), 1095–1102 (1993).
  • Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. BE j Radiol. 70,130–139 (1997).
  • Nevin J, Soeters R, Dehaeck K, Bloch B, Van Wyk L. Cervical carcinoma associated with pregnancy. Obstet. Gynecol Surv 50(3), 228–239 (1995).
  • Norstrom A, Jansson I, Andersson H. Carcinoma of the uterine cervix in pregnancy. A study of the incidence and treatment in the western region of Sweden 1973 to 1992. Acta Obstet. Gynecol Scand 76(6), 583–589 (1997).
  • Hacker NF, Berek JS, Lagasse LD, Charles EH, Savage EW, Moore JG. Carcinoma of the cervix associated with pregnancy. Obstet. Gynecol 59(6), 735–746 (1982).
  • Duggan B, Muderspach LI, Roman LD, Curtin JP, d'Ablaing G III, Morrow CR Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet. Gynecol 82(4 Pt 1), 598–602 (1993).
  • •Good review of cases of cervical cancer in pregnancy including patients with postponed therapy.
  • Sivanesaratnam V, Jayalakshmi P, Loo C. Surgical management of early invasive cancer of the cervix associated with pregnancy. Gynecol Oncol 48(1), 68–75 (1993).
  • Jones WB, Shingleton HM, Russell A et al. Cervical carcinoma and pregnancy. A national patterns of care study of the American College of Surgeons. Cancer 77(8), 1479–1488 (1996).
  • Lee RB, Neglia W Park RC. Cervical carcinoma in pregnancy. Obstet. Gynecol 58(5), 584–589 (1981).
  • Method MW, Brost BC. Management of cervical cancer in pregnancy. Sernin. Surg. Oncol 16(3), 251–260 (1999).
  • •Comprehensive review of cervical cancer in pregnancy
  • Economos K, Perez VN, Delke I, Collado ML, Tancer ML. Abnormal cervical cytology in pregnancy: a 17-year experience. Obstet. Gynecol 81(6), 915–918 (1993).
  • Sood AK, Sorosky JI, Krogman S, Anderson B, Benda J, Buller RE. Surgical management of cervical cancer complicating pregnancy: a case-control study. Gynecol Oncol 63(3), 294–298 (1996).
  • Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and fetal outcome after invasive cervical cancer in pregnancy. J. Clin. Oncol 9(11), 1956-1961 (1991).
  • Prem IKA, Makowski EL, McKelvey JL. Carcinoma of the cervix associated with pregnancy. Am. J Obstet. Gynecol 95 (1), 99–108 (1966).
  • Thompson JD, Caputo TA, Franklin EW III, Dale E. The surgical management of invasive cancer of the cervix in pregnancy. Arn. I Obstet. Gynecol 121(6), 853–863 (1975).
  • Greer BE, Easterling TR, McLennan DA et al Fetal and maternal considerations in the management of Stage TB cervical cancer during pregnancy. Gynecol Oncol 34(1), 61–65 (1989).
  • Hopkins MP, Morley GW. The prognosis and management of cervical cancer associated with pregnancy. Obstet. Gynecol 80(1), 9–13 (1992).
  • Monk BJ, Montz FJ. Invasive cervical cancer complicating intrauterine pregnancy: treatment with radical hysterectomy. Obstet. Gynecol 80(2), 199–203 (1992).
  • Sorosky JI, Squatrito R, Ndubisi BU et al Stage I squamous cell cervical carcinoma in pregnancy: planned delay in therapy awaiting fetal maturity. Gynecol Oncol 59(2), 207–210 (1995).
  • Hopkins MP, Lavin JR Cervical cancer in pregnancy. Gynecol Oncol 63(3), 293 (1996).
  • Hertel H, Possover M, Kuhne-Heid R, Schneider A. Laparoscopic lymph node staging of cervical cancer in the 19th week of pregnancy. A case report. Surg. Endosc 15(3), 324 (2001).
  • Tewari K, Cappuccini F, Balderston KD, Rose GS, Porto M, Berman ML. Pregnancy in a Jehovah's witness with cervical cancer and anemia. Gynecol Oncol 71(2), 330–332 (1998).
  • •Important article presenting neoadjuvant chemotherapy in pregnancy.
  • Giacalone PL, Laffargue F, Benos P, Rousseau O, Hedon B. Cisplatinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix. BE j Obstet. Gynaecol 103(9), 932–934 (1996).
  • •Important article presenting neoadjuvant chemotherapy in pregnancy.
  • Cliby WA, Dodson MK, Podratz KC. Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery. Obstet. Gynecol 84(2), 179–182 (1994).
  • van der Vange N, Weverling GJ, Ketting BW, Ankum WM, Samlal R, Lammes FB. The prognosis of cervical cancer associated with pregnancy: a matched cohort study. Obstet. Gynecol 85(6), 1022–1026 (1995).
  • Ostrom K, Ben Arie A, Edwards C, Gregg A, Chiu JK, Kaplan AL. Uterine evacuation with misoprostol during radiotherapy for cervical cancer in pregnancy. Int. J. Gynecol Cancer 13(3), 340–343 (2003).
  • Sood AK, Sorosky JI, Mayr N et al. Radiotherapeutic management of cervical carcinoma that complicates pregnancy. Cancer80(6), 1073–1078 (1997).
  • Bosch A, Marcial VA. Carcinoma of the uterine cervix associated with pregnancy. Am J. Roentgenol Radium. Ther Nucl. Med. 96(1), 92–99 (1966).
  • Rugo HS. Management of breast cancer diagnosed during pregnancy. CI.117: Treat. Options Oncol 4(2), 165–173 (2003).
  • •Comprehensive review of breast cancer in pregnancy
  • Anderson JM. Mammary cancers and pregnancy. BE Med J1(6171), 1124–1127 (1979).
  • Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am.j Obstet. Gynecol 184(7), 1504–1512 (2001).
  • Parente JT, Amsel M, Lerner R, Chinea F. Breast cancer associated with pregnancy. Obstet. Gynecol 71(6 Pt 1), 861–864 (1988).
  • DiFronzo LA, O'Connell TX. Breast cancer in pregnancy and lactation. Surg. Clin. North Am. 76(2), 267–278 (1996).
  • Gallenberg MM, Loprinzi CL. Breast cancer and pregnancy. Semin. Oncol 16(5), 369–376 (1989).
  • Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer 67(4), 869–872 (1991).
  • Bottles K, Taylor RN. Diagnosis of breast masses in pregnant and lactating women by aspiration cytology. Obstet. Gynecol 66\(Suppl. 3), 76S-78S (1985).
  • Ishida T, Yokoe T, Kasumi F et al Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn. J. Cancer Res. 83(11), 1143–1149 (1992).
  • Mitre BK, Kanbour AI, Mauser N. Fine needle aspiration biopsy of breast carcinoma in pregnancy and lactation. Acta Cytol. 41(4), 1121–1130 (1997).
  • Harbert JC, Rocha L, Smith FP, Delgado G. The efficacy of radionuclide liver and bone scans in the evaluation of gynecologic cancers. Cancer 49(5), 1040–1042 (1982).
  • Fiorica JV. Special problems. Breast cancer and pregnancy. Obstet. Cynecol Clin. North Am. 21(4), 721–732 (1994).
  • Lauenstein TC, Freudenberg LS, Goehde SC et al Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur. Radiol. 12(8), 2091–2099 (2002).
  • Nugent P, O'Connell TX. Breast cancer and pregnancy. Arch. Surg. 120(11), 1221–1224 (1985).
  • Ribeiro G, Jones DA, Jones M. Carcinoma of the breast associated with pregnancy. Br. Stag 73(8), 607–609 (1986).
  • •Series of 121 patients with carcinoma of the breast diagnosed during pregnancy
  • Zemlickis D, Lishner M, Degendorfer P et al Maternal and fetal outcome after breast cancer in pregnancy. Am. J. Obstet. Cynecol 166(3), 781–787 (1992).
  • Reed W, Sandstad B, Holm R, Nesland JM. The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators. Int. J. Stag Pathol 11(2), 65–74 (2003).
  • Hindle W Gonzalez S. Diagnosis, and treatment of invasive breast cancer during pregnancy and lactation. Clin. Obstet. Cynecol 45(3), 770–773 (2002).
  • Elledge RM, Ciocca DR, Langone G, McGuire WL. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer 71(8), 2499–2506 (1993).
  • Marchant DJ. Breast cancer in pregnancy. Clin. Obstet. Cynecol 37(4), 993–997 (1994).
  • Keleher AJ, Theriault RL, Gwyn KM et al. Multidisciplinary management of breast cancer concurrent with pregnancy. J. Am Coll Sing 194(1), 54–64 (2002).
  • •Important review emphasizing the multidisciplinary approach to cancer in pregnancy
  • Merkel DE. Pregnancy and breast cancer. Semin. &lig Oncol 12(5), 370–375 (1996).
  • Byrd BF Jr, Stephenson SE, Burch JC, Sawyers JL, Tinsley EA. Type of mastectomy in cancer of the breast: analysis of 1765 cases. Ann. Sing 163(5), 746–750 (1966).
  • Singletary SE. New approaches to surgery for breast cancer. Endocr Relat. Cancer8 (4), 265–286 (2001).
  • Krontiras H, Bland KI. When is sentinel node biopsy for breast cancer contraindicated? Stag Oncol 12 (3), 207–210 (2003).
  • Morita ET Lymphoscintigraphy in the detection of sentinel lymph nodes. Cancer Teat. Res. 111,9–37(2002).
  • Fisher B, Redmond C, Brown A et al. Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project trial. J. Clin. Oncol 4(4), 459–471 (1986).
  • Kuerer HM, Gwyn K, Ames FC, Theriault RL. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgely131 (1), 108–110 (2002).
  • Ebert U, Loffier H, Kirch W Cytotoxic therapy and pregnancy. Phatmacol Ther. 74(2), 207–220 (1997).
  • •Important paper suggesting conservative treatment during pregnancy.
  • Leslie KK. Chemotherapy and pregnancy. Clin. Obstet. Cynecol 45(1), 153–164 (2002).
  • Berry DL, Theriault RL, Holmes FA et al. Management of breast cancer during pregnancy using a standardized protocol. Clin. Oncol 17(3), 855–861 (1999).
  • d'Incalci M, Broggini M, Buscaglia M, Pardi G. Transplacental passage of doxorubicin. Lancet 1(8314–1315), 75 (1983).
  • Nulman I, Laslo D, Fried S, Uleryk E, Lishner M, Koren G. Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br. Cancer 85(11), 1611–1618 (2001).
  • Halakivi-Clarke L, Cho E, Onojafe I, Liao DJ, Clarke R. Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring. Clin. Cancer Res. 6(1), 305–308 (2000).
  • Tewari K, Bonebrake RG, Asrat T, Shanberg AM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet350(9072), 183 (1997).
  • Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy — case report and literature review. Cynecol Oncol 80(3), 405–408 (2001).
  • Dildy GA III, Moise KJ Jr, Carpenter RJ Jr, Klima T Maternal malignancy metastatic to the products of conception: a review. Obstet Cynecol Surrc 44(7), 535–540 (1989).
  • ••Very important and well cited paperreviewing metastases to the placenta and fetus.
  • Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. jAm. Acad. Detmatol 34(5 Pt 1), 839–847 (1996).
  • Colbourn DS, Nathanson L, Belilos E. Pregnancy and malignant melanoma. Semin. Oncol 16(5), 377–387 (1989).
  • Potter JF, Schoeneman M. Metastasis of maternal cancer to the placenta and fetus. Cancer25(2), 380–388 (1970).
  • George PA, Fortner JG, Pack GT. Melanoma with pregnancy. A report of 115 cases. Cancer 13,854–859 (1960).
  • Grin CM, Driscoll MS, Grant-Kels JM. Pregnancy and the prognosis of malignant melanoma. Semin. Oncol 23(6), 734–736 (1996).
  • Houghton AN, Flannery J, Viola MV. Malignant melanoma of the skin occurring during pregnancy. Cancer 48 (2), 407–410 (1981).
  • Sutherland CM, Loutfi A, Mather FJ, Carter RD, Krementz ET Effect of pregnancy upon malignant melanoma. Surg. Cynecol Obstet. 157(5), 443–446 (1983).
  • Shiu MET, Schottenfeld D, Maclean B, Fortner JG. Adverse effect of pregnancy on melanoma: a reappraisal. Cancer 37(1), 181–187 (1976).
  • McManamny DS, Moss AL, Pocock PV, Briggs JC. Melanoma and pregnancy: a long-term follow-up. BE j Obstet. Cynaecol 96(12), 1419–1423 (1989).
  • Wong JH, Sterns EE, Kopald KH, Nizze JA, Morton DL. Prognostic significance of pregnancy in Stage I melanoma. Arch. Surg. 124(10), 1227–1230 (1989).
  • Wong DJ, Strassner HT Melanoma in pregnancy. Clin. Obstet. Cynecol 33(4), 782–791 (1990).
  • MacKie RM, Bufalino R, Morabito A, Sutherland C, Cascinelli N. Lack of effect of pregnancy on outcome of melanoma. For the World Health Organization Melanoma Program. Lancet 337(8742), 653–655 (1991).
  • Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ. Pregnancy and early-stage melanoma. Cancer97(9), 2248–2253 (2003).
  • Reintgen DS, McCarty KS Jr, Vollmer R, Cox E, Seigler HE Malignant melanoma and pregnancy. Cancer 55(6), 1340–1344 (1985).
  • Slingluff CL Jr, Reintgen DS, Vollmer RT, Seigler HF. Malignant melanoma arising during pregnancy. A study of 100 patients. Ann. Surg. 211(5), 552–557 (1990).
  • Veronesi U, Cascinelli N, Adamus J et al. Thin Stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl. J. Med. 318(18), 1159–1162 (1988).
  • Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch. Surg. 126(4), 438–441 (1991).
  • Krag DN, Meijer SJ, Weaver DL et al. Minimal-access surgery for staging of malignant melanoma. Arch. Surg. 130(6), 654–658 (1995).
  • Wornom IL III, Smith JW, Soong SJ, McElvein R, Urist MM, Balch CM. Surgery as palliative treatment for distant metastases of melanoma. Ann. Surg. 204(2), 181–185 (1986).
  • Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RII. Interferon-aa, adjuvant therapyof high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.1 Gun. Oncol 14(1), 7–17 (1996).
  • Baer MR. Normal full-term pregnancy in a patient with chronic myelogenous leukemia treated with a-interferon. Am. J. Hematol 37(1), 66 (1991).
  • Sokoto H, Karamitsos J, Kundaria B, DiSaia PJ. Case report of interferon-a therapy for multiple myeloma during pregnancy. Am. J. Obstet. Gynecol 172(1 Pt 1), 217–219 (1995).
  • Brossard J, Abish S, Bernstein ML, Baruchel S, Kovacs L, Pollack R. Maternal malignancy involving the products of conception: a report of malignant melanoma and medulloblastoma. Am. J. Pecliatc Hematol °rico'. 16(4), 380–383 (1994).
  • Haas JF. Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. int. J. Cancer 34(2), 229–235 (1984).
  • Ward FT, Weiss RB. Lymphoma and pregnancy. Semin. Oncol 16(5), 397–409 (1989).
  • Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and foetal outcome following Hodgkin's disease in pregnancy. BE j Cancer65(1), 114–117 (1992).
  • Barry RM, Diamond HD, Craver LE Influence of pregnancy on the course of Hodgkin's disease. Am. J. Obstet. Gynecol 84,445–454 (1962).
  • Gobbi PG, Attardo-Parrinello A, Danesino M et al Hodgkin's disease and pregnancy. Haematologica 69(3), 336–341 (1984).
  • Nisce LZ, Tome MA, He S, Lee BJ III, Kutcher GJ. Management of coexisting Hodgkin's disease and pregnancy. Am. J. Oncol 9(2), 146–151 (1986).
  • Koren G, Lishner M, Farine D. Cancer in Pregnancy: Maternal and Fetal Risks. Cambridge University Press, Cambridge, UK (1996).
  • Peleg D, Ben Ami M. Lymphoma and leukemia complicating pregnancy. Obstet. Gynecol Gun. North Am. 25(2), 365–383 (1998).
  • Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the pregnant patient with Hodgkin's disease. Ann. Intern. Med. 95(6), 669–675 (1981).
  • Gelb AB, van de Rijn M, Warnke RA, Kamel OW Pregnancy-associated lymphomas. A clinicopathologic study. Cancer 78 (2), 304–310 (1996) .
  • Serraino D, Pezzotti P, Dorrucci M, Alliegro MB, Sinicco A, Rezza G. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer79(5), 1004–1008 (1997).
  • Aviles A, Diaz-Maqueo JC, Torras V, Garcia EL, Guzman R. Non-Hodgkin's lymphomas and pregnancy: presentation of 16 cases. Gynecol °rico'. 37(3), 335–337 (1990).
  • Devita VT Jr, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology Lippincott—Raven, PA, USA (1997).
  • Briggs GG. DITTS il7 Pleb71317Cy and Lactation: a Reference Guide to Fetal and Neonatal Risk. Lippincott Williams & Wilkins, MD, USA (1999).
  • Wiebe VJ, Sipila PE. Pharmacology of antineoplastic agents in pregnancy. Crit. Rev Oncol Hematol 16(2), 75–112 (1994).
  • Shotton D, Monie IW. Possible teratogenic effect of chlorambucil on a human fetus. JAMA 186,74–75 (1963).
  • Steege JF, Caldwell DS. Renal agenesis after first trimester exposure to chlorambucil. South Med J. 73(10), 1414–1415 (1980).
  • Rugh R, Skaredoff L. Radiation and radiomimetric chlorambucil and the fetal retina. Arch. Ophthalmol 74,382–393 (1965).
  • Nicholson HO. Cytotoxic drugs in pregnancy. Review of reported cases. Obstet. Gynaecol BE Cominonw 75(3), 307–312 (1968).
  • Enns GM, Roeder E, Chan RT, Ali-Khan CZ, Cox VA, Golabi M. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Am. J. Med. Genet. 86(3), 237–241 (1999).
  • Pizzuto J, Aviles A, Noriega L, Niz J, Morales M, Romero E Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat. Rep. 64(4-5), 679–683 (1980).
  • Gilliland J, Weinstein L. The effects of cancer chemotherapeutic agents on the developing fetus. Obstet. Gynecol Surv. 38(1), 6–13 (1983).
  • Murray CL, Reichert JA, Anderson J, Twiggs LB. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report. JAIVIA 252(18), 2607–2608 (1984).
  • Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int. J. Gynecol Cancer 12 (4), 399–402 (2002).
  • Achtari C, Hohlfeld P Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J. Obstet. Gynecol 183(2), 511–512 (2000).
  • Raffles A, Williams J, Costeloe K, Clark P. Transplacental effects of maternal cancer chemotherapy. Case report. BE j Obstet Gynaecol 96(9), 1099–1100 (1989).
  • Warkany J. Aminopterin and methotrexate: folic acid deficiency. TiTatology17(3), 353–357 (1978).
  • Goetsch C. An evaluation of aminopterin as an abortifacient. Am. J. Obstet. Gynecol 83,1474–1477 (1962).
  • Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum. 40(5), 971–973 (1997).
  • Milunsky A, Graef JW, Gaynor ME Jr. Methotrexate-induced congenital malformations. J. Pecliatc 72(6), 790–795 (1968).
  • Wagner VM, Hill JS, Weaver D, Baehner RL. Congenital abnormalities in baby born to cytarabine treated mother. Lancet2(8185), 98–99 (1980).
  • Schleuning M, Clemm C. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. N EngLJ Med. 317(26), 1666–1667 (1987).
  • Volkenandt M, Buchner T, Hiddemann W, Van de Loo J. Acute leukaemia during pregnancy. Lancet 2 (8574), 1521–1522 (1987).
  • Tomlinson MW Treadwell MC, Deppe G. Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy. Eur Gynaecol. Oncol. 18(1), 44–46 (1997).
  • Mendez LE, Mueller A, Salom E, Gonzalez-Quintero VH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet. Gynecol. 102(5 Pt 2), 1200–1202 (2003).
  • Gadducci A, Cosio S, Fanucchi A et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res. 23(6D), 5225–5229 (2003).
  • Mulvihill JJ, McKeen EA, Rosner F, Zarrabi ME. Pregnancy outcome in cancer patients. Experience in a large co-operative group. Cancer60(5), 1143–1150 (1987).
  • Feldkamp M, Carey JC. Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy. 7eratology47(6), 533–539 (1993).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.